Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea
· Delayed Price · Currency is KRW 4,780.00
-80.00 (-1.65%)
At close: Mar 26, 2025, 3:30 PM KST
Korea Arlico Pharm Revenue
In the year 2024, Korea Arlico Pharm had annual revenue of 190.44B KRW with 1.75% growth. Korea Arlico Pharm had revenue of 52.33B in the quarter ending December 31, 2024, with 17.72% growth.
Revenue
190.44B
Revenue Growth
+1.75%
P/S Ratio
0.37
Revenue / Employee
1.70B
Employees
112
Market Cap
71.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 190.44B | 3.28B | 1.75% |
| Dec 31, 2023 | 187.15B | 19.42B | 11.58% |
| Dec 31, 2022 | 167.74B | 27.58B | 19.68% |
| Dec 31, 2021 | 140.16B | 15.35B | 12.30% |
| Dec 31, 2020 | 124.81B | 9.02B | 7.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |